Searched for
ANTI COVID DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
In the shadow of COVID, health officials fight panic over Hantavirus outbreakA hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...
'Thalapathy' Vijay takes charge as Chief Minister of Tamil NaduC Joseph Vijay took oath as Tamil Nadu Chief Minister. His government is the first non-DMK and non-AIADMK administration in six decades. Vi...
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
Themis Medicare’s anti-viral COVID drug gets DCGI nodMumbai-based pharmaceutical company Themis Medicare’s anti-viral drug Viralex has received Drugs Controller General of India’s (DCGI) appro...
Maharashtra company starts human trials of drug aimed at mild, moderate cases of COVID-19World's largest vaccine maker Serum Institute of India is the sponsor of the Pune-headquartered iSERA Biological Pvt Ltd's drug project, wh...
IICT ties up with Nosch Labs for transfer of process knowhow to make anti-Covid drug 2-DGA press release here on Monday said as per the pact signed on June 11, Nosch Labs would commence manufacture of 2-DG drug after obtaining r...
Bombay HC asks Maharashtra govt how Sonu Sood, MLA Zeeshan Siddique procured anti-Covid drugsThe court also observed that "these people projected themselves as some kind of messiah."
DRDO's anti-COVID drug priced at Rs 990 per sachet; Centre, states to get discountsThe first batch of DRDO's anti-Covid-19 drug was released on May 17 by Defence Minister Rajnath Singh and health minister Dr Harsh Vardhan,...
Assam Chief Minister hails scientist Dr.Jubilee Purkayastha for developing anti-COVID drugsIn a congratulatory letter to Dr. Purkayastha on Wednesday, Chief Minister Sarma, said, "Assam is really proud of you for your role in seve...
Dr Reddy’s warns public on spurious versions of 2DG, its anti-Covid drug, in the market“2DG is an oral antiviral drug that can be administered only upon prescription to hospitalized moderate to severe Covid-19 patients as adju...
Will examine data of 2-DG drug for adding it to national COVID treatment protocol: GovtNITI Aayog member (health) Dr V K Paul said Drugs Controller General of India has granted permission for emergency use of the drug after lo...
Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients todayThe first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation o...
DCGI approves anti-COVID drug developed by DRDO for emergency useAccording to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D...
Do not neglect anti-Covid drugsAs the virus continues to mutate, vaccines developed for previous versions might cease to be effective. Antiviral drugs are, therefore, gai...
Russian produced anti-covid drug ready for exportsThe Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russ...
Over 50 Covid-19 candidates under clinical trials in IndiaOver 50 clinical trials for a Covid-19 vaccine have started in India as researchers globally look for ways to stop the ravaging pandemic.